Germany approves Rheacell's cell therapy product Amesanar® for the use in patients with chronic wounds Chronic wounds not only put great strain on the health system, but also have a major impact on the quality of life of affected patients. Rheacell, a German biopharmaceutical company focused on clinical development of…..
